| # | Title | Journal | Year | Citations |
|---|
| 1 | CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines | Radiotherapy and Oncology | 2003 | 611 |
| 2 | Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method | International Journal of Radiation Oncology Biology Physics | 2001 | 261 |
| 3 | Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 | International Journal of Radiation Oncology Biology Physics | 2000 | 254 |
| 4 | Fraction size in external beam radiation therapy in the treatment of melanoma | International Journal of Radiation Oncology Biology Physics | 1991 | 243 |
| 5 | Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease | Annals of Oncology | 2017 | 203 |
| 6 | Clinical Trials in Recurrent Ovarian Cancer | International Journal of Gynecological Cancer | 2011 | 186 |
| 7 | A Phase II Trial of Brachytherapy Alone After Lumpectomy for Select Breast Cancer: Tumor Control and Survival Outcomes of RTOG 95-17 | International Journal of Radiation Oncology Biology Physics | 2008 | 163 |
| 8 | The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies | International Journal of Radiation Oncology Biology Physics | 1999 | 124 |
| 9 | Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials | International Journal of Radiation Oncology Biology Physics | 1999 | 105 |
| 10 | Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: phase II study of the radiation therapy oncology group 92-10 | International Journal of Radiation Oncology Biology Physics | 1998 | 77 |
| 11 | Does neoadjuvant hormone treatment compromise subsequent androgen suppression in prostate cancer patients who fail initial radiation therapy: a secondary analysis of RTOG 86-10 | International Journal of Radiation Oncology Biology Physics | 2000 | 77 |
| 12 | RTOG 0631 Phase II/III Study of Image-guided Stereotactic Radiosurgery for Localized Spine Metastases: Phase II Results | International Journal of Radiation Oncology Biology Physics | 2011 | 70 |
| 13 | RTOG's first quality of life study—RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer | International Journal of Radiation Oncology Biology Physics | 1995 | 69 |
| 14 | Hyperthermia quality assurance guidelines | International Journal of Radiation Oncology Biology Physics | 1989 | 56 |
| 15 | Irradiation with or without misonidazole for patients with stages IIIb and IVa carcinoma of the cervix: final results of RTOG 80-05 | International Journal of Radiation Oncology Biology Physics | 1999 | 55 |
| 16 | Radiation therapy quality assurance in clinical trials – Global harmonisation group | Radiotherapy and Oncology | 2014 | 55 |
| 17 | Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10 | International Journal of Radiation Oncology Biology Physics | 2006 | 47 |
| 18 | CT characteristics of patients with brain metastases treated in rtog study 79-16 | International Journal of Radiation Oncology Biology Physics | 1993 | 45 |
| 19 | The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Analysis of Radiation Therapy Oncology Group Trials | Journal of Thoracic Oncology | 2010 | 45 |
| 20 | Prostate-Specific Antigen Levels are Higher in African-American Than in White Patients in a Multicenter Registration Study: Results of RTOG 94-12 | International Journal of Radiation Oncology Biology Physics | 1998 | 43 |
| 21 | Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients | International Journal of Radiation Oncology Biology Physics | 2003 | 40 |
| 22 | Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03 | Journal of Neuro-Oncology | 2009 | 40 |
| 23 | A phase III trial comparing whole-pelvic (WP) to prostate only (PO) radiotherapy and neoadjuvant to adjuvant total androgen suppression (TAS): preliminary analysis of RTOG 9413 | International Journal of Radiation Oncology Biology Physics | 2001 | 37 |
| 24 | Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens | Annals of Oncology | 2005 | 37 |
| 25 | Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours | Annals of Oncology | 2017 | 33 |
| 26 | Randomized prospective comparison of stereotactic radiosurgery (SRS) followed by conventional radiotherapy (RT) with BCNU to RT with BCNU alone for selected patients with supratentorial glioblastoma multiforme (GBM): report of RTOG 93-05 protocol | International Journal of Radiation Oncology Biology Physics | 2002 | 28 |
| 27 | Long Term Outcomes of RTOG 90–03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma | International Journal of Radiation Oncology Biology Physics | 2005 | 28 |
| 28 | A Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination with Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Report of Efficacy and Toxicity | International Journal of Radiation Oncology Biology Physics | 2010 | 28 |
| 29 | Phase III randomized trial of 8 Gy in 1 fraction vs. 30 Gy in 10 fractions for palliation of painful bone metastases: preliminary results of RTOG 97-14 | International Journal of Radiation Oncology Biology Physics | 2003 | 27 |
| 30 | Phase I/II Trial of a COX-2 Inhibitor With Limited Field Radiation for Intermediate Prognosis Patients Who Have Locally Advanced Non–Small-Cell Lung Cancer: Radiation Therapy Oncology Group 0213 | Clinical Lung Cancer | 2011 | 24 |
| 31 | Quality of Life (QOL) Analysis of the Randomized Radiation (RT) Dose-Escalation NSCLC Trial (RTOG 0617): The Rest of the Story | International Journal of Radiation Oncology Biology Physics | 2013 | 24 |
| 32 | Androgen suppression adjuvant to radiotherapy in carcinoma of the prostate. long-term results of phase III RTOG study 85-31 | International Journal of Radiation Oncology Biology Physics | 2003 | 23 |
| 33 | Recursive partitioning analysis (RPA) of pre-treatment variables for 416 patients with loco-regional esophageal cancer treated with concomitant chemoradiotherapy (CT-RT) on intergroup and radiation therapy oncology group (RTOG) trials | International Journal of Radiation Oncology Biology Physics | 2002 | 21 |
| 34 | Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): results of the radiation therapy oncology group (RTOG) 98–01 study | International Journal of Radiation Oncology Biology Physics | 2003 | 21 |
| 35 | Modeling small group learning | Instructional Science | 2004 | 20 |
| 36 | Evaluation of nuclear factor κB and chemokine receptor CXCR4 co‐expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610 | BJU International | 2011 | 20 |
| 37 | Practice Patterns of Radiotherapy in Endometrial Cancer Among Member Groups of the Gynecologic Cancer Intergroup | International Journal of Gynecological Cancer | 2009 | 19 |
| 38 | An Update of the Phase III Trial Comparing Whole-Pelvic (WP) to Prostate Only (PO) Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression (TAS): Updated Analysis of RTOG 94-13 | International Journal of Radiation Oncology Biology Physics | 2005 | 16 |
| 39 | Progression free survival (PFS) after whole-pelvic (WP) vs. mini-pelvic (MP) or prostate only (PO) radiotherapy (RT): A subset analysis of RTOG 9413, a Phase III prospective randomized trial using neoadjuvant and concurrent (N&CHT) | International Journal of Radiation Oncology Biology Physics | 2004 | 14 |
| 40 | A phase II study of external irradiation and weekly paclitaxel for non-metastatic, unresectable pancreatic cancer: a preliminary report of RTOG Protocol 98-12 | International Journal of Radiation Oncology Biology Physics | 2001 | 9 |
| 41 | Prospective health-related quality of life valuations (utilities) of 8 Gy in 1 fraction vs 30 Gy in 10 fractions for palliation of painful bone metastases: Preliminary results of RTOG 97–14 | International Journal of Radiation Oncology Biology Physics | 2004 | 9 |
| 42 | A Phase II Study of a Paclitaxel Based Chemoradiation Regimen With Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246 | International Journal of Radiation Oncology Biology Physics | 2007 | 9 |
| 43 | Phase II Study of Paclitaxel and Cisplatin in Combination with Split Course Concomitant Hyperfractionated Re-Irradiation in Patients with Recurrent Squamous Cell Cancer of the Head and Neck: Results of RTOG 99-11 | International Journal of Radiation Oncology Biology Physics | 2005 | 7 |
| 44 | 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration | Annals of Oncology | 2005 | 7 |
| 45 | HUMAN ENT1 IS PREDICTIVE OF RESPONSE IN PATIENTS WITH PANCREATIC CANCER TREATED WITH GEMCITABINE | Pancreas | 2007 | 6 |
| 46 | A Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: RTOG PA0411 | International Journal of Radiation Oncology Biology Physics | 2007 | 6 |
| 47 | The Globalization of Cooperative Groups | Seminars in Oncology | 2015 | 6 |
| 48 | RTOG 9705, a phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIA non-small cell lung cancer (NSCLC) patients — promising long term survival results | International Journal of Radiation Oncology Biology Physics | 2003 | 5 |
| 49 | Quality of Cervical Cancer Brachytherapy Implantation in RTOG Prospective Trials | International Journal of Radiation Oncology Biology Physics | 2009 | 5 |
| 50 | Progression free survival (PFS) after whole-pelvic (WP) vs. mini-pelvic (MP) or prostate only (PO) radiotherapy (RT): A subset analysis of RTOG 9413, a Phase III prospective randomized trial using neoadjuvant and concurrent (N&CHT) | International Journal of Radiation Oncology Biology Physics | 2004 | 4 |
